ArticleMedicine2026
Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between programmed cell death (PCD) and atrial fibrillation (AF), as well as the underlying genetic mechanisms, remains unclear. This study aimed to evaluate the causal relationships between PCD-related genes and AF using a multi-omics approach, involving Mendelian randomization (MR) and colocalization analyses. Genome-wide association studies summary statistics regarding PCD-related gene methylation, gene expression, and protein abundance were acquired from relevant studies, and 1073 PCD-related genes were analyzed. The reliability of the MR estimates was evaluated through colocalization analysis complemented by Steiger directionality test. At the methylation level, 568 cytosine-phosphate-guanine sites were mapped to 260 PCD-related genes with significant causal associations with AF. Notably, 333 genes were associated with AF risk at the expression level, and 95 plasma proteins were causally related to AF. By integrating evidence from multi-omics, we identified 8 tier 1 genes with strong multi-omics evidence. Furthermore, 3 and 27 genes were identified as AF tier 2 and 3 genes, respectively. This study provides compelling evidence of the involvement of PCD in the pathogenesis of AF, thereby advancing our understanding of the mechanism underlying AF. The identification of PCD-related genes linked to AF highlights their potential as diagnostic and therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.